Alma Prieto-Tenreiro Selected Research

Insulin (Novolin)

10/2020	The challenge of diabetes home control in COVID-19 times: Proof is in the pudding.
4/2012	[Benefits of subcutaneous continuous insulin infusion in type 1 diabetic patients with high glycemic variability].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alma Prieto-Tenreiro Research Topics

Disease

3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2020 - 04/2012
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2023
1	Type 2 Diabetes Mellitus (MODY) 01/2023
1	Hypoglycemia (Reactive Hypoglycemia) 04/2012
1	Thyroid Diseases (Thyroid Disease) 04/2010
1	Hypothyroidism 04/2010
1	Pituitary Neoplasms (Pituitary Adenoma) 01/2010
1	Hyperthyroidism 01/2010
1	Neoplasms (Cancer) 01/2010

Drug/Important Bio-Agent (IBA)

2	Insulin (Novolin)FDA Link 10/2020 - 04/2012
2	Glucose (Dextrose)FDA LinkGeneric 02/2013 - 04/2012
2	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 04/2010 - 01/2010
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023
1	LipidsIBA 01/2023
1	Pituitary HormonesIBA 04/2010
1	Thyrotropin-Releasing Hormone (Protirelin)FDA Link 04/2010

Therapy/Procedure

3	Therapeutics 01/2023 - 01/2010
1	Injections 10/2020
1	Glycemic Control 10/2020